ANIP Stock Rises 7% in a Week: Here's What You Should Know

Key Takeaways ANIP shares rose after the company issued full-year 2026 guidance that beat Wall Street expectations.ANI Pharma forecasts 2026 sales of $1.055-$1.115B and EPS of $8.83-$9.34, with ~60% from rare diseases.ANIP expects Cortrophin Gel sales of $540-$575M in 2026, driven by higher demand and prescriber adoption.Shares of ANI Pharmaceuticals (ANIP) have risen 7% in the past week, all thanks to the recently announced financial guidance for the full year 2026 that surpassed Wall Street expectations.A ...